HIV Infection

The Glucocorticoid Antagonist RU-486 Suppresses HIV Infectivity and Replication.

Published March 15, 2013

The Glucocorticoid Antagonist RU-486 Suppresses HIV Infectivity and Replication.

J Neuropsychiatry Clin Neurosci. 2013 Mar 1; 25(1): 51-7
Benton TD, Lynch KG, Dubé B, Gettes DR, Tustin NB, Metzger DS, Blume J, Douglas SD, Evans DL

The effects of… Continue reading →

[Addiction to Ephedrine in Psychiatric Disorders].

Published March 15, 2013

[Addiction to ephedrine in psychiatric disorders].

Adicciones. 2013; 25(1): 89-90
Martínez-Quintana E, Rodríguez-González F

HubMed – addiction

EMCDDA Best Practice Promotion in Europe: an Internet based dissemination tool.

Adicciones. 2013; 25(1): 3-6
Ferri M, Bo A

Best… Continue reading →

Outcomes of Antiretroviral Therapy in Vietnam: Results From a National Evaluation.

Published March 6, 2013

Outcomes of antiretroviral therapy in Vietnam: results from a national evaluation.

PLoS One. 2013; 8(2): e55750
Nguyen DB, Do NT, Shiraishi RW, Le YN, Tran QH, Huu Nguyen H, Medland N, Nguyen LT, Struminger BB

Vietnam has significantly scaled… Continue reading →

The Combined Propranolol/TSST Paradigm – a New Method for Psychoneuroendocrinology.

Published March 2, 2013

The Combined Propranolol/TSST Paradigm – A New Method for Psychoneuroendocrinology.

PLoS One. 2013; 8(2): e57567
Andrews J, Pruessner JC

Upon perception of a stimulus as stressful, the human brain reacts with the activation of the hypothalamus-pituitary-adrenal (HPA) axis and… Continue reading →

Cognitive Neurorehabilitation of HIV-Associated Neurocognitive Disorders: A Qualitative Review and Call to Action.

Published February 19, 2013

Cognitive Neurorehabilitation of HIV-associated Neurocognitive Disorders: A Qualitative Review and Call to Action.

Filed under: Rehab Centers

Neuropsychol Rev. 2013 Feb 16;
Weber E, Blackstone K, Woods SP

Despite significant advances in the virologic management of HIV infection over… Continue reading →

Posttraumatic Stress Disorder, Depression, and HIV Risk Behavior Among Ohio Army National Guard Soldiers.

Published February 19, 2013

Posttraumatic Stress Disorder, Depression, and HIV Risk Behavior Among Ohio Army National Guard Soldiers.

Filed under: Depression Treatment

J Trauma Stress. 2013 Feb; 26(1): 64-70
Marshall BD, Prescott MR, Liberzon I, Tamburrino MB, Calabrese JR, Galea S

We examined… Continue reading →

Depression Treatment: [A Man With Sexual Disinhibition Caused by Paraneoplastic Limbic Encephalitis].

Published February 15, 2013

[A man with sexual disinhibition caused by paraneoplastic limbic encephalitis].

Filed under: Depression Treatment

Tijdschr Psychiatr. 2013; 55(2): 129-33
de Vries CL, Koers H

SUMMARY: A 63-year-old man with symptoms of depression and sexual disinhibition was admitted to a… Continue reading →

Why the Treatment of Mental Disorders Is an Important Component of HIV Prevention Among People Who Inject Drugs.

Published February 13, 2013

Why the Treatment of Mental Disorders Is an Important Component of HIV Prevention among People Who Inject Drugs.

Filed under: Addiction Rehab

Adv Prev Med. 2013; 2013: 690386
Buckingham E, Schrage E, Cournos F

People who inject drugs are… Continue reading →

Striatal Glutamate Release in L-DOPA-Induced Dyskinetic Animals.

Published February 8, 2013

Striatal Glutamate Release in l-DOPA-Induced Dyskinetic Animals.

Filed under: Drug and Alcohol Rehabilitation

PLoS One. 2013; 8(2): e55706
Nevalainen N, Lundblad M, Gerhardt GA, Strömberg I

l-DOPA-induced dyskinesia is a common side effect developed after chronic treatment with 3,4-dihydroxyphenyl-l-alanine… Continue reading →

What Did People in Mental Institutions Do?